(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HYLO INTENSE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

HYLO INTENSE

ST13

US500000079310179

Class

5

Filing

79310179

Registration

6641661

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

05/08/2025

Trademark type

Word

Nice classes

5

Filing date

11/16/2020

Registration date

02/15/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/15/2022

Last transaction

05/08/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

DE

Examiner

RUSKIN, MATTHEW

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

URSAPHARM Arzneimittel GmbH

Representatives

Ellen A. Andelman Moore & Van Allen PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticalmedical and veterinary preparationsophthalmologic preparations and eye drops; pharmaceutical preparations for ophthalmological use; pharmaceutical and veterinary preparations for the treatment of ophthalmological conditionsdiseases and disorders; contact lens cleaning preparations; solutions for contact lenses; rinsing solutions for contact lenses; disinfectants for contact lenses; moisturizing solutions for contact lenses; solutions for neutralizing contact lenses; medicinal creams for the treatment of ophthalmological conditionsdiseases and disorders; pharmaceutical creams for the treatment of ophthalmological conditionsdiseases and disorders; eye ointments for the treatment of ophthalmological conditionsdiseases and disorders; eye drops; ophthalmic preparations

Publications

History of USPTO decisions and trademark events.

27 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/08/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/16/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/22/2022

FIMP

FINAL DISPOSITION PROCESSED

07/22/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/15/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

02/15/2022

GPNX

NOTIFICATION PROCESSED BY IB

12/13/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/30/2021

PUBO

PUBLISHED FOR OPPOSITION

11/30/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/17/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/17/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/10/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/25/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/22/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/22/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/22/2021

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

08/13/2021

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

08/07/2021

RFNT

REFUSAL PROCESSED BY IB

06/13/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/24/2021

RFRR

REFUSAL PROCESSED BY MPU

05/24/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/22/2021

CNRT

NON-FINAL ACTION WRITTEN

05/21/2021

MAFR

APPLICATION FILING RECEIPT MAILED

05/15/2021

DOCK

ASSIGNED TO EXAMINER

05/11/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/11/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/08/2021

Continuous trademark protection

Get notified about every new filing that threatens HYLO INTENSE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.